Katie Kortbein
Life Sciences Intern
Information Technology and Innovation Foundation
Katie Kortbein is a life sciences intern at ITIF. She is pursuing a master's degree from Georgetown University in Biohazardous Threat Agents & Emerging Infectious Diseases.
Research Areas
Recent Publications
July 22, 2026
The FDA Should Not Allow Untested Peptides to Be Added Into Patients’ Medications
The FDA is considering allowing seven unapproved peptides—largely sourced through a Chinese gray market—to be used by U.S. compounding pharmacies, despite its own scientists warning against it. Approving them would legitimize unvetted foreign suppliers and undermine evidence-based drug regulation.
